1. Upregulation of meiosis-specific genes in lymphoma cell lines following genotoxic insult and induction of mitotic catastrophe. Kalejs, M., Ivanov, A., Plakhins, G., Cragg, M. S., Emzinsh, D., Illidge, T. M., Erenpreisa, J., BMC Cancer, 2006. 6: p. 6.
  2. Protection of azidothymidine-induced cardiopathology in mice by mildronate, a mitochondria-targeted drug.Klusa V, Pupure J, Isajevs S, Rumaks J, Gordjushina V, Kratovska A, Taivans I, Svirskis S, Viksna L, Kalvinsh I., Basic Clin Pharmacol Toxicol, 2006. 99(4): p. 323-8.
  3. The adiponectin gene is associated with adiponectin levels but not with characteristics of the insulin resistance syndrome in healthy Caucasians. Mackevics, V., Heid, I. M., Wagner, S. A., Cip, P., Doppelmayr, H., Lejnieks, A., Gohlke, H., Ladurner, G., Illig, T., Iglseder, B., Kronenberg, F., Paulweber, B.., Eur J Hum Genet, 2006. 14(3): p. 349-56.
  4. Increased intra-abdominal pressure: is it of any consequence in severe acute pancreatitis?Pupelis, G., Plaudis, H., Snippe, K., Rudakovska, M.,HPB (Oxford), 2006. 8(3): p. 227-32.
  5. Early oral feeding in acute pancreatitis: an alternative approach to tube feeding.Pupelis, G., Snippe, K., Plaudis, H., Rudakovska, M.,Preliminary report. Acta Chir Belg, 2006. 106(2): p. 181-6.
  6. Cancer risk among Chernobyl cleanup workers in Estonia and Latvia, 1986-1998. Rahu, M., Rahu, K., Auvinen, A., Tekkel, M., Stengrevics, A., Hakulinen, T., Boice, J. D., Jr., Inskip, P. D., Int J Cancer, 2006. 119(1): p. 162-8.
  7. Helicobacter pylori infection among children with gastrointestinal symptoms: a high prevalence of infection among patients with reflux oesophagitis.Daugule, I., Rumba, I., Alksnis, J., Ejderhamn, J., Acta Paediatr, 2007. 96(7): p. 1047-9.
  8. sRAGE and esRAGE are not associated with peripheral or autonomic neuropathy in type 2 diabetes. Humpert, P.M., et al.,Horm Metab Res, 2007. 39(12): p. 899-902.
  9. Precancerous gastric conditions in high Helicobacter pylori prevalence areas: comparison between Eastern European (Lithuanian, Latvian) and Asian (Taiwanese) patients.Jonaitis, , Ivanauskas, A., Janciauskas, D., Funka, K., Sudraba, A., Tolmanis, I., Krams, A., Stirna, D., Vanags, A., Kupcinskas, L., Leja, M., Lin, J. T., Medicina (Kaunas), 2007. 43(8): p. 623-9.
  10. Resources and management strategies for the use of radiotherapy in the treatment of lung cancer in Central and Eastern European countries: results of an International Atomic Energy Agency (IAEA) survey.Kepka L, Danilova V, Saghatelyan T, Bajcsay A, Utehina O, Stojanovic S, Yalman D, Demiral A, Bondaruk O, Kuddu M, Jeremic B, Lung Cancer, 2007. 56(2): p. 235-45.
  11. Should we screen for Helicobacter pylori to prevent gastric cancer?Leja, M. and D.L. Dumitrascu, Dig Dis, 2007. 25(3): p. 218-21.
  12. CDKN2A and CDK4 variants in Latvian melanoma patients: analysis of a clinic-based population. Pjanova, D., Engele, L., Randerson-Moor, J. A., Harland, M., Bishop, D. T., Newton Bishop, J. A., Taylor, C., Debniak, T., Lubinski, J., Kleina, R., Heisele, O., Melanoma Res, 2007. 17(3): p. 185-91.
  13. Continuous veno-venous haemofiltration in the treatment of severe acute pancreatitis: 6-year experience.Pupelis, G., Plaudis, H., Grigane, A., Zeiza, K., Purmalis, G.,HPB (Oxford), 2007. 9(4): p. 295-301.
  14. Improved vascular function upon pioglitazone treatment in type 2 diabetes is not associated with changes in mononuclear NF-kappaB binding activity. Rudofsky, G., Jr., Reismann, P., Grafe, I. A., Konrade, I., Djuric, Z., Tafel, J., Buchbinder, S., Zorn, M., Humpert, P. M., Hamann, A., Morcos, M., Nawroth, P. P., Bierhaus, A.,Horm Metab Res, 2007. 39(9): p. 665-71.
  15. DNR analysis results in thromboses patients: the first data in Latvia.Lejniece S. Lejnieks, Steinbergs J, Vasiljeva I, Boka V, Udre I.J thromb Haemost 20078;5 Suppl2:P-T-425.
  16. The impact of osteoporosis on radiometric indices of the edentulous jaws. Ozola B., Slaidina A., Soboleva U., Lejnieks A. Abstract book, Kaunas (Lithuania), May 11-12, 2007; pg.53.
  17. The impact of osteoporosis on radiomorphometric indices of the edentulous jaws. Slaidina A., Soboleva U., Nikitina E., Ozola B., Lejnieks A. Programme & Abstract Book, Malmö, Sweeden, August 16-18, 2007; pg. 25.
  18. Validity of mandibular radiomorphometric indices for identifying risk of osteoporosis. Slaidina A., Soboleva U., Rogovska I., Lejnieks A. 12th Meeting of the International College of Prosthodontists. Programme & Abstract Book, Fukuoka, Japan, September 5-8, 2007, pg. 175.
  19. Anemia in Chronic Kidney Disease: Under-recognized and Under-treated.Kuzema V., Petersons A., Lejnieks A.: J Am Soc Nephrol 18 (abstract), 2007 (in press).
  20. Verminderte Glyoxalase-1 Aktivät in Patienten mit scmerzhaften diabetischen Neuropathie. Konrade I., Skapare E., Dombrova M., Lejnieks A., Stoynova SB., Haag GM., Humpert PM., Nawroth PP., Bierhaus A. Diabetologie und Stoffwechesel; S1,2007:S39 (abstract P98)
  21. Verminderte Glyoxalase-1 Aktivät bei Patienten mit schmerzhatfter diabeticher Neuopathie. Konrade I. Skapare E., Dambrova M., Lenieks A., Liepins E., Stoyanov V., Haag GM., Humpert PM.22nd Symposium of the Federation of Internationa Danube-Symposiua on Diabetes Mellitus 2nd Central Europena Diabetic Congress; Diabetologie und Stoffwechesel Helt 4/2007,abstract A9 (24)
  22. Effectiveness of different right ventricular pacing sites after AV node ablation in permanent atrial fibrillation. Kalejs O, Nesterovics N, Bumbergs M, Vikmane M, Jubele K, Sipacevs P, Kamzola G, Ansabergs J, Stabulniece M, Jirgensons J, Lejnieks A. Journal of Cardiovascular Electrophysiology.2007;Vol.18:Suppl2,S26 (and oral presentation in Venice Arrhytmias Internationa Workshop on Cardiac Arrhytmias, October 7-101, 2007).
  23. Should we screen for Helicobacter pylori to prevent gastric cancer? Leja M., Dumitrascu D.L Digestive Diseases; 25 (3):2:18-21
  24. Natural clearance of hepatitis C virus infection and human leukocyte antigen class II alleles in children with haemophilia. Lejniece S., Simanis R., Eglite J., Viksna L., Sochnevs A., Kovalova Z. J Thromb Haemost 2007; 5 Supplement 2: P-T-425
  25. Helicobacter pylori infection in children. Daugule, I. and M. Rowland, Helicobacter, 2008. 13 Suppl 1: p. 41-6.
  26. Evaluation of T7 and lambda phage display systems for survey of autoantibody profiles in cancer patients.Kalnina, Z., Silina, K., Meistere, I., Zayakin, P., Rivosh, A., Abols, A., Leja, M., Minenkova, O., Schadendorf, D., Line, A.,J Immunol Methods, 2008. 334(1-2): p. 37-50.
  27. Risk of hematological malignancies among Chernobyl liquidators. Kesminiene A, Evrard AS, Ivanov VK, Malakhova IV, Kurtinaitis J, Stengrevics A, Tekkel M, Anspaugh LR, Bouville A, Chekin S, Chumak VV, Drozdovitch V, Gapanovich V, Golovanov I, Hubert P, Illichev SV, Khait SE, Kryuchkov VP, Maceika E, Maksyoutov M, Mirkhaidarov AK, Polyakov S, Shchukina N, Tenet V, Tserakhovich TI, Tsykalo A, Tukov AR, Cardis E., Radiat Res, 2008. 170(6): p. 721-35.
  28. Incidence and clinical significance of parvovirus B19 infection in patients with rheumatoid arthritis. Kozireva SV, Zestkova JV, Mikazane HJ, Kadisa AL, Kakurina NA, Lejnieks AA, Danilane IN, Murovska MF.,J Rheumatol, 2008. 35(7): p. 1265-70.
  29. Impact of hyperbaric oxygen therapy on the clinical course of acute pancreatitis and systemic inflammation response syndrome.Lisagors, I.L., et al., Anesteziol Reanimatol, 2008(4): p. 34-8.
  30. Conservative approach in the management of severe acute pancreatitis: eight-year experience in a single institution. Pupelis, G., Zeiza, K., Plaudis, H., Suhova, A., HPB (Oxford), 2008. 10(5): p. 347-55.
  31. Distinct influence of atypical 1,4-dihydropyridine compounds in azidothymidine-induced neuro- and cardiotoxicity in mice ex vivo. Pupure, J., Isajevs, S., Gordjushina, V., Taivans, I., Rumaks, J., Svirskis, S., Kratovska, A., Dzirkale, Z., Pilipenko, J., Duburs, G., Klusa, V.,Basic Clin Pharmacol Toxicol, 2008. 103(5): p. 401-6.
  32. Helicobacter pylori and non-malignant diseases. Shirin, H., M. Leja, and Y. Niv,Helicobacter, 2008. 13 Suppl 1: p. 23-7.
  33. Natural clearance of hepatitis C virus in hemophilia patients.Simanis, R., Lejniece, S., Sochnevs, A., Eglite, J., Chernevska, G., Kovalova, Z., Gardovska, D., Jeruma, A., Kuse, V., Viksna, L.,Medicina (Kaunas), 2008. 44(1): p. 15-21.
  34. Surgical treatment of gastric cancer in Latvia: Results of centralized experience. Sivins, A., Pedrazzani, C., Roviello, F., Ancans, G., Timofejevs, M., Pcholkins, A., Krumins, V., Boka, V., Stengrevics, A., Leja, M.,Eur J Surg Oncol, 2008.
  35. A Parkinsonian syndrome in methcathinone users and the role of manganese.Stepens, A.,Logina, I., Liguts, V., Aldins, P., Eksteina, I., Platkajis, A., Martinsone, I., Terauds, E., Rozentale, B., Donaghy, M., A N Engl J Med, 2008. 358(10): p. 1009-17.
  36. Surgical treatment of gastric cancer in Latvia: results of centralized experience. Sivins, A., et al., Eur J Surg Oncol, 2009. 35(5): p. 481-5.
  37. Analysis of cardiac and pulmonary complication probabilities after radiation therapy for patients with early-stage breast cancer. Utehina, O., et al., Medicina (Kaunas), 2009. 45(4): p. 276-85.
  38. Identification of a CDK4 R24H mutation-positive melanoma family by analysis of early-onset melanoma patients in Latvia. Pjanova, D., et al., Melanoma Res, 2009. 19(2): p. 119-22.
  39. Expression of the CD117, COX-2 and HSP90 antigens and cell proliferation in fine-needle-aspirated cells from metastatic melanomas.Sviatoha, V., et al.,Anticancer Res, 2009. 29(11): p. 4345-52.
  40. Immunohistochemical analysis of the S100A1, S100B, CD44 and Bcl-2 antigens and the rate of cell proliferation assessed by Ki-67 antibody in benign and malignant melanocytic tumours. Sviatoha, V., et al., Melanoma Res, 2009.
  41. Three-dimensional evaluation of TMJ parameters in Class II and Class III patients. Krisjane, Z., et al., Stomatologija, 2009. 11(1): p. 32-6.
  42. Three-dimensional evaluation of musculoskeletal in Class II and Class III patients. Zepa, K., et al.,Stomatologija,2009. 11(1): p. 15-20.
  43. The validity of a biomarker method for indirect detection of gastric mucosal atrophy versus standard histopathology. Leja, M., et al., Dig Dis Sci, 2009. 54(11): p. 2377-84.
  44. Molecular characterisation and expression analysis of SEREX-defined antigen NUCB2 in gastric epithelium, gastritis and gastric cancer.Kalnina, Z., et al.,Eur J Histochem, 2009. 53(1): p. 7-18.
  45. Relation of inflammatory chemokines to insulin resistance and hypoadiponectinemia in coronary artery disease patients. Tretjakovs, P., et al.,Eur J Intern Med, 2009. 20(7): p. 712-7.
  46. Repeated prevalence studies on antibiotic use in Latvia, 2003-2007.Dimina, E., et al.,Euro Surveill, 2009. 14(33).
  47. Decreased FOXP3 expression in small airways of smokers with COPD.Isajevs, S., et al.,Eur Respir J, 2009. 33(1): p. 61-7.
  48. Neuroprotective properties of mildronate, a mitochondria-targeted small molecule. Pupure, J., et al.,Neurosci Lett, 2010. 470(2): p. 100-5.
  49. New "loop" suture for FDP zone I injuries. Kapickis, M., Tech Hand Up Extrem Surg, 2009. 13(3): p. 141-4.
  50. Kudaba I, Boka V, Strumfa I, Berzins J, Teibe U. Clinical and histopathological diagnostic algorithm for carcinoma of unknown primary (CUP) patients// Innovations and Technology News, 2009; 2:11-20.
  51. Evaluation of two types of vascular bundles for revascularization of avascular tissue.Kapickis, M., P. Sassu, and S.M. Thirkannad, J Hand Surg Am, 2009.34(8): p.1461-6
  52. Steger, G.G., J. Abrahamova, F. Bacanu, S. Brincat, A. Brize, A. Cesas, T. Cufer, M. Dank, R. Duchnowska, A. Eniu, J. Jassem, Z. Kahan, E. Matos, P. Padrik, S. Plate, H. Pokker, G. Purkalne, C. Timcheva, V. Tzekova, R. Vyzula, and C.C. Zielinski, Current standards in the treatment of metastatic breast cancer with focus on Lapatinib: a review by a Central European Consensus Panel. Wien Klin Wochenschr, 2010. 122(11-12): p. 368-79.
  53. Viberga, I., L. Engele, and P. Baili, Past, present and future of the cervical cancer screening in Latvia. Tumori, 2010. 96(4): p. 529-37.
  54. Klusa, V.Z., S. Isajevs, D. Svirina, J. Pupure, U. Beitnere, J. Rumaks, S. Svirskis, B. Jansone, Z. Dzirkale, R. Muceniece, I. Kalvinsh, and H.V. Vinters, Neuroprotective properties of mildronate, a small molecule, in a rat model of Parkinson's disease. Int J Mol Sci, 2010. 11(11): p. 4465-87.
  55. Rostoka, E., S. Isajevs, L. Baumane, A. Line, K. Silina, M. Dzintare, J. Sharipova, D. Svirina, I. Kalvinsh, and N. Sjakste, Effects of lycopene, indole-3-carbinol, and luteolin on nitric oxide production and iNOS expression are organ-specific in rats. Arh Hig Rada Toksikol, 2010. 61(3): p. 275-85.
  56. Sokolovska, J., S. Isajevs, O. Sugoka, J. Sharipova, L. Lauberte, D. Svirina, E. Rostoka, T. Sjakste, I. Kalvinsh, and N. Sjakste, Influence of metformin on GLUT1 gene and protein expression in rat streptozotocin diabetes mellitus model. Arch Physiol Biochem, 2010. 116(3): p. 137-45.
  57. Rostoka, E., L. Baumane, S. Isajevs, A. Line, M. Dzintare, D. Svirina, J. Sharipova, K. Silina, I. Kalvinsh, and N. Sjakste, Effects of kaempferol and myricetin on inducible nitric oxide synthase expression and nitric oxide production in rats. Basic Clin Pharmacol Toxicol, 2010. 106(6): p. 461-6.
  58. Pupure, J., S. Isajevs, E. Skapare, J. Rumaks, S. Svirskis, D. Svirina, I. Kalvinsh, and V. Klusa, Neuroprotective properties of mildronate, a mitochondria-targeted small molecule. Neurosci Lett, 2010. 470(2): p. 100-5.
  59. Kapickis, M., A. Lahiri, and A.Y. Lim, Different angiogenic behaviour of ligated saphenous and epigastric vascular bundles in avascular environment: an in-vivo experimental study. Hand Surg, 2010. 15(1): p. 17-25.
  60. Sviatoha, V., E. Tani, M. Ghaderi, R. Kleina, and L. Skoog, Assessment of V600E mutation of BRAF gene and rate of cell proliferation using fine-needle aspirates from metastatic melanomas. Anticancer Res, 2010. 30(9): p. 3267-72.
  61. Sviatoha, V., E. Tani, R. Kleina, M. Sperga, and L. Skoog, Immunohistochemical analysis of the S100A1, S100B, CD44 and Bcl-2 antigens and the rate of cell proliferation assessed by Ki-67 antibody in benign and malignant melanocytic tumours. Melanoma Res, 2010. 20(2): p. 118-25.
  62. Cattaneo, A., T. Burmaz, M. Arendt, I. Nilsson, K. Mikiel-Kostyra, I. Kondrate, M.J. Communal, C. Massart, E. Chapin, and M. Fallon, Protection, promotion and support of breast-feeding in Europe: progress from 2002 to 2007. Public Health Nutr, 2010. 13(6): p. 751-9.
  63. Ruger, D., W. Harzer, Z. Krisjane, and E. Tausche, Shear bond strength after multiple bracket bonding with or without repeated etching. Eur J Orthod, 2010.
  64. Jakobsone, G., L. Neimane, and G. Krumina, Two- and three-dimensional evaluation of the upper airway after bimaxillary correction of Class III malocclusion. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2010. 110(2): p. 234-42.
  65. Kupcinskas, L., T. Wex, J. Kupcinskas, M. Leja, A. Ivanauskas, L.V. Jonaitis, D. Janciauskas, G. Kiudelis, K. Funka, A. Sudraba, H.M. Chiu, J.T. Lin, and P. Malfertheiner, Interleukin-1B and interleukin-1 receptor antagonist gene polymorphisms are not associated with premalignant gastric conditions: a combined haplotype analysis. Eur J Gastroenterol Hepatol, 2010. 22(10): p. 1189-95.
  66. Pedrazzani, C., A. Sivins, G. Ancans, D. Marrelli, G. Corso, V. Krumins, F. Roviello, and M. Leja, Ratio between metastatic and examined lymph nodes (N ratio) may have low clinical utility in gastric cancer patients treated by limited lymphadenectomy: results from a single-center experience of 526 patients. World J Surg, 2010. 34(1): p. 85-91.
  67. Petzer, A.L., D. Wolf, D. Fong, T. Lion, I. Dyagil, Z. Masliak, A. Bogdanovic, L. Griskevicius, S. Lejniece, S. Goranov, L. Gercheva, A. Stojanovic, D. Peytchev, N. Tzvetkov, R. Griniute, R. Oucheva, H. Ulmer, M. Kwakkelstein, F. Rancati, and G. Gastl, High-dose imatinib improves cytogenetic and molecular remissions in patients with pretreated Philadelphia-positive, BCR-ABL-positive chronic phase chronic myeloid leukemia: first results from the randomized CELSG phase III CML 11 "ISTAHIT" study. Haematologica, 2010. 95(6): p. 908-13.
  68. Cserni, G., I. Amendoeira, S. Bianchi, E. Chmielik, J. Degaetano, D. Faverly, P. Figueiredo, M.P. Foschini, D. Grabau, J. Jacquemier, H. Kaya, J. Kulka, M. Lacerda, I. Liepniece-Karele, J.M. Penuela, C. Quinn, P. Regitnig, A. Reiner-Concin, A. Sapino, P.J. van Diest, Z. Varga, V. Vezzosi, J. Wesseling, V. Zolota, E. Zozaya, and C.A. Wells, Distinction of isolated tumour cells and micrometastasis in lymph nodes of breast cancer patients according to the new Tumour Node Metastasis (TNM) definitions. Eur J Cancer, 2010.
  69. Stepens, A., C.J. Stagg, A. Platkajis, M.H. Boudrias, H. Johansen-Berg, and M. Donaghy, White matter abnormalities in methcathinone abusers with an extrapyramidal syndrome. Brain, 2010. 133(Pt 12): p. 3676-84.
  70. Pirker, R., P. Berzinec, S. Brincat, P. Kasan, G. Ostoros, M. Pesek, S. Plate, G. Purkalne, R. Rooneem, J. Skrickova, D. Stanculeanu, C. Timcheva, V. Tzekova, B. Zakotnik, C.C. Zielinski, and M. Zwitter, Therapy of small cell lung cancer with emphasis on oral topotecan. Lung Cancer, 2010. 70(1): p. 7-13.
  71. Zodzika, J., D. Rezeberga, I. Jermakova, O. Vasina, N. Vedmedovska, and G. Donders, Factors related to elevated vaginal pH in the first trimester of pregnancy. Acta Obstet Gynecol Scand, 2011. 90(1): p. 41-6.
  72. Vedmedovska, N., D. Rezeberga, U. Teibe, I. Melderis, and G.G. Donders, Placental pathology in fetal growth restriction. Eur J Obstet Gynecol Reprod Biol, 2010.
  73. Vedmedovska, N., D. Rezeberga, U. Teibe, I. Melderis, and G.G. Donders, Microscopic lesions of placenta and Doppler velocimetry related to fetal growth restriction. Arch Gynecol Obstet, 2010.
  74. Vedmedovska, N., D. Rezeberga, U. Teibe, J. Zodzika, and G.G. Donders, Preventable maternal risk factors and association of genital infection with fetal growth restriction. Gynecol Obstet Invest, 2010. 70(4): p. 291-8.
  75. Vedmedovska, N., D. Rezeberga, U. Teibe, S. Polukarova, and G.G. Donders, Fetal growth restriction in Latvia. Int J Gynaecol Obstet, 2010. 111(2): p. 185-6.
  76. Pedrazzani, C., D. Marrelli, A. Sivins, and F. Roviello, Minimum number of removed and examined lymph nodes is essential in gastric cancer patients: reply to letter. World J Surg, 2010. 34(5): p. 1138-9.
  77. Tars, K., J. Rumnieks, A. Zeltins, A. Kazaks, S. Kotelovica, A. Leonciks, J. Sharipo, A. Viksna, J. Kuka, E. Liepinsh, and M. Dambrova, Crystal structure of human gamma-butyrobetaine hydroxylase. Biochem Biophys Res Commun, 2010. 398(4): p. 634-9.
  78. Sherrill, B., A. Di Leo, M.M. Amonkar, Y. Wu, Z. Zvirbule, Z. Aziz, J. Bines, and H.L. Gomez, Quality-of-life and quality-adjusted survival (Q-TWiST) in patients receiving lapatinib in combination with paclitaxel as first-line treatment for metastatic breast cancer. Curr Med Res Opin, 2010. 26(4): p. 767-75.
  79. De Robertis E, Tomins P, Knape H. Anaesthesiologists in emergency medicine: the desirableF manpower. Eur J Anaesthesiol. 2010 Mar;27(3):223-5.
  80. Petzer, A., Wolf, D., Fong, D., Lion, Th., Dyagil, I., Masliak, Z., Bogdanovic, A., Griskevicius, L., Lejniece, S., et al. High-dose imatinib improves cytogenetic and molecular remissions in patients with pretreated Philadelphia-positive, BCR-ABL-positive chronic phase chronic myeloid leukemia: first results from the randomized CELSG phase III CML 11 "ISTAHIT" study. Haematologica. 2010 June; 95(6): 908–913.
  81. Leja M, Kojalo U, Frickauss G, Bandere B, Gavars D, Boka V.

Changing patterns of serological testing for celiac disease in Latvia.

J Gastrointestin Liver Dis. 2011 Jun;20(2):121-6.

  1. Berzina A, Azarjana K, Cema I, Pjanova D, Rivosh A. Prognostic factors and epidemiological characteristics of cutaneous and mucosal head and neck melanoma.

Stomatologija. 2011;13(2):49-54.

  1. Macuks R, Baidekalna I, Donina S. Comparison of different ovarian cancer detection algorithms. Eur J Gynaecol Oncol. 2011;32(4):408-10.
  2. Macuks R, Baidekalna I, Donina S.

Diagnostic test for ovarian cancer composed of ovarian cancer symptom index, menopausal status and ovarian cancer antigen CA125. Eur J Gynaecol Oncol. 2011;32(3):286-8.

  1. Franckeviča I, Kleina R, Voika O. Originally misdiagnosed rhabdoid tumour of the kidney. A case report and differential diagnosis. Pol J Pathol. 2011 Sep;62(3):163-7.
  2. Kazanceva A, Groma V, Smane L, Kornevs E, Teibe U. Proliferative potential in benign mixed salivary gland tumors and its value in primary and recurrent neoplasms. Stomatologija. 2011;13(2):35-41.
  3. Krumina G. Other dementias. Neuroradiology. 2011 Sep;53 Suppl 1:S149-60.
  4. Strazdina A, Krumina G, Sperga M. The value and limitations of contrast-enhanced ultrasound in detection of prostate cancer. Anticancer Res. 2011 Apr;31(4):1421-6.
  5. Sudraba A, Daugule I, Rudzite D, Funka K, Tolmanis I, Engstrand L, Janciauskas D, Jonaitis L, Kiudelis G, Kupcinskas L, Ivanauskas A, Leja M. Performance of routine Helicobacter pylori tests in patients with atrophic gastritis. J Gastrointestin Liver Dis. 2011 Dec;20(4):349-54.
  6. Leja M, Kupcinskas L, Funka K, Sudraba A, Jonaitis L, Ivanauskas A, Janciauskas D, Kuidelis G, Chiu HM, Lin JT. Value of gastrin-17 in detecting antral atrophy. Adv Med Sci. 2011;56(2):145-50.
  7. Leja M, Reardon MJ. Cardiac sarcomas: therapeutic options? Future Cardiol. 2011 Sep;7(5):595-7.
  8. Kupcinskas J, Wex T, Bornschein J, Selgrad M, Leja M, Juozaityte E, Kiudelis G, Jonaitis L, Malfertheiner P. Lack of association between gene polymorphisms of Angiotensin converting enzyme, Nod-like receptor 1, Toll-like receptor 4, FAS/FASL and the presence of Helicobacter pylori-induced premalignant gastric lesions and gastric cancer in Caucasians. BMC Med Genet. 2011 Aug 24;12:112.
  9. Daugule I, Sudraba A, Chiu HM, Funka K, Ivanauskas A, Janciauskas D, Jonaitis L, Kiudelis G, Tolmanis I, Vanags A, Lin JT, Kupcinskas L, Leja M. Gastric plasma biomarkers and Operative Link for Gastritis Assessment gastritis stage. Eur J Gastroenterol Hepatol. 2011 Apr;23(4):302-7.
  10. Siliņa K, Zayakin P, Kalniņa Z, Ivanova L, Meistere I, Endzeliņš E, Abols A, Stengrēvics A, Leja M, Ducena K, Kozirovskis V, Linē A. Sperm-associated antigens as targets for cancer immunotherapy: expression pattern and humoral immune response in cancer patients. J Immunother. 2011 Jan;34(1):28-44.
  11. Lejniece S, Murovska M, Chapenko S, Breikša B, Jaunmuktane Z, Feldmane L, Ziediņa I, Gomez-Roman J, Garcia-Cabeza M, Lejnieks A. Progressive multifocal leukoencephalopathy following fludarabine treatment in a chronic lymphocytic leukemia patient. Exp Oncol. 2011 Dec;33(4):239-41.
  12. Rivkina A, Vitols G, Murovska M, Lejniece S.Identifying the stage of new CLL patients using TK, ZAP-70, CD38 levels. Exp Oncol. 2011 Jun;33(2):99-103.
  13. Stukena I, Apanavičienė DA, Bahs G, Kalvelis A, Dzerve V, Ansmite B, Kalejs O, Lejnieks A. Blood pressure control in treated hypertensive patients in daily practice of Latvian family physicians. Medicina (Kaunas). 2011;47(10):586-92.
  14. Slaidina A, Soboleva U, Daukste I, Zvaigzne A, Lejnieks A. Postmenopausal osteoporosis and tooth loss. Stomatologija. 2011;13(3):92-5.
  15. Ozola B, Slaidina A, Laurina L, Soboleva U, Lejnieks A. The influence of bone mineral density and body mass index on resorption of edentulous jaws. Stomatologija. 2011;13(1):19-24
  16. Cserni G, Amendoeira I, Bianchi S, Chmielik E, Degaetano J, Faverly D, Figueiredo P, Foschini MP, Grabau D, Jacquemier J, Kaya H, Kulka J, Lacerda M, Liepniece-Karele I, Penuela JM, Quinn C, Regitnig P, Reiner-Concin A, Sapino A, van Diest PJ, Varga Z, Vezzosi V, Wesseling J, Zolota V, Zozaya E, Wells CA. Distinction of isolated tumour cells and micrometastasis in lymph nodes of breast cancer patients according to the new Tumour Node Metastasis (TNM) definitions. Eur J Cancer. 2011 Apr;47(6):887-94. Epub 2010 Dec 16
  17. Mihailova A, Mikazane H, Klovins J, Nikitina-Zake L. Association of protein tyrosine phosphatase non-receptor 22 (PTPN22) rs2476601 and Kruppel-like factor 12 (KLF12) rs1324913 single nucleotide polymorphisms with rheumatoid arthritis in a Latvian population. Scand J Rheumatol. 2011 Nov;40(6):491-2
  18. Nora-Krukle Z, Chapenko S, Logina I, Millers A, Platkajis A, Murovska M. Human herpesvirus 6 and 7 reactivation and disease activity in multiple sclerosis. Medicina (Kaunas). 2011;47(10):527-31.
  19. Martins K, Lahiri A, Pupelis G. Surgical treatment of neurogenic thoracic outlet syndrome secondary to the clavicle haematogenic subacute osteomyelitis. Hand Surg. 2011;16(2):161-5.
  20. Isajevs S, Isajeva D, Beitnere U, Jansone B, Kalvinsh I, Klusa V. Mildronate as a regulator of protein expression in a rat model of Parkinson's disease. Medicina (Kaunas). 2011;47(10):552-9.
  21. Sokolovska J, Isajevs S, Sugoka O, Sharipova J, Lauberte L, Svirina D, Rostoka E, Sjakste T, Kalvinsh I, Sjakste N. Correction of glycaemia and GLUT1 level by mildronate in rat streptozotocin diabetes mellitus model. Cell Biochem Funct. 2011 Jan-Feb;29(1):55-63. doi: 10.1002/cbf.1719.
  22. Isajevs S, Taivans I, Svirina D, Strazda G, Kopeika U. Patterns of inflammatory responses in large and small airways in smokers with and without chronic obstructive pulmonary disease. Respiration. 2011;81(5):362-71. Epub 2011 Jan 12.
  23. Strazdina A, Krumina G, Sperga M. The value and limitations of contrast-enhanced ultrasound in detection of prostate cancer. Anticancer Res. 2011 Apr;31(4):1421-6.
  24. Donders G, Bellen G, Rezeberga D. Aerobic vaginitis in pregnancy. BJOG. 2011 Sep;118(10):1163-70. doi: 10.1111/j.1471-0528.2011.03020.x. Epub 2011 Jun 14. Review.
  25. Zodzika J, Rezeberga D, Jermakova I, Vasina O, Vedmedovska N, Donders G.

Factors related to elevated vaginal pH in the first trimester of pregnancy. Acta Obstet Gynecol Scand. 2011 Jan;90(1):41-6. doi: 10.1111/j.1600-0412.2010.01011.x. Epub 2010 Nov 26.